Seeking Alpha
 

GlycoMimetics (GLYC)

- NASDAQ
  • ewmpsi | Send Message 6 Jan

    $GLYC GlycoMimetics : Assigned Patent http://bit.ly/14giEde
    Reply
      • Shelby Cardozo | Send Message 4 Jan

        GlycoMimetics: The $57.2 Million IPO Anniversary $GLYC http://seekingalpha.com/a/1nx21
        Reply
          • ewmpsi | Send Message 18 Dec 2014

            $BABA backs away from todays high, $MSFT up 2.5%, $TSLA up 3.5%, $GLYC Director Michael A. Henos unloaded 6,725 shares, $NOK back above $8
            Reply
              • ewmpsi | Send Message 17 Dec 2014

                #OIL trying to bottom, #energy trying to bounce, market gets a bid: $TSLA back above key level of >$200, $BABA up +2%, $GLYC testing $9
                Reply
                  • ewmpsi | Send Message 9 Dec 2014

                    GlycoMimetics Highlights Potential Therapeutic Benefits of Its Novel E-Selectin... $GLYC http://bit.ly/1wZ1Aol via @benzinga
                    Reply
                      • Eric Muathe | Send Message 20 Nov 2014
                        Reply
                          • ewmpsi | Send Message 20 Nov 2014

                            $BABA bounce, $GLYC up on up-side potential, $TSLA now Audi wants "in" on electric, http://bit.ly/1uNeZhm
                            Reply
                              • ewmpsi | Send Message 20 Nov 2014

                                $GLYC #Glycomimetics Catalyst Stifel's Biotech Catalyst Stock to Buy With 60% to 100% Upside Potential http://bit.ly/11jI4oD
                                Reply
                                  • ewmpsi | Send Message 18 Nov 2014

                                    $NOK back to $8 and $GLYC pops to $8 off of GMI-1271 phase one trial results
                                    Reply
                                      • ewmpsi | Send Message 31 Oct 2014

                                        $BABA tries to take out its 52wk high, $MSFT Microsoft Band: A health tracker on steroids http://yhoo.it/1rGoZ5M $GLYC earnings release
                                        Reply
                                          Visit Seeking Alpha's
                                          GLYC vs. ETF Alternatives
                                          Company Description
                                          GlycoMimetics Inc is a clinical stage biotechnology company. The Company is engaged in discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States